HALE DAVID F

Insider Reports History

Location
Encinitas, CA
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HALE DAVID F:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Director Common Stock 29,673 $268,244 $9.04 23 Feb 2024 By Hale BioPharma Ventures, LLC
BIOCEPT INC Director Common Stock 3,114 $12,663 $4.07 09 Dec 2021 By LLC
Oncternal Therapeutics, Inc. Director Common Stock 917 $8,290 $9.04 23 Feb 2024 By Hale Trading Company
Oncternal Therapeutics, Inc. Director Common Stock 714 $6,455 $9.04 23 Feb 2024 Direct
BIOCEPT INC Director Common Stock 796 $3,237 $4.07 09 Dec 2021 Direct
BIOCEPT INC Director Common Stock 101 $411 $4.07 09 Dec 2021 By trust
Dermata Therapeutics, Inc. Director Common Stock 80,957 23 Jan 2025 By Hale BioPharma Ventures LLC
Dermata Therapeutics, Inc. Director Warrant (Right to Buy) 78,741 21 Jan 2025 By Hale BioPharma Ventures LLC
Oncternal Therapeutics, Inc. Director Stock Options 3,300 20 Jun 2024 Direct
Dermata Therapeutics, Inc. Director Stock Option (Right to Buy) 2,500 02 Jan 2026 Direct
Dermata Therapeutics, Inc. Director Common Stock 314 21 Jan 2025 Direct
Dermata Therapeutics, Inc. Director Common Stock 148 21 Jan 2025 By Hale Family Trust
Dermata Therapeutics, Inc. Director Common Stock 50 21 Jan 2025 By Hale Trading Company L.P.

Insider Reports Filed by HALE DAVID F

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DRMA Dermata Therapeutics, Inc. 02 Jan 2026 1 $0 4 Director 06 Jan 2026, 20:00
DRMA Dermata Therapeutics, Inc. 21 Jan 2025 2 $0 4 Director 23 Jan 2025, 17:00
DRMA Dermata Therapeutics, Inc. 13 Jan 2025 1 $0 4 Director 14 Jan 2025, 18:56
/report/000095017024076698-hale-david-f-2024-06-20 Oncternal Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 16:05
/report/000120919124004016-hale-david-f-2024-02-23 Oncternal Therapeutics, Inc. 23 Feb 2024 2 +$8,859 4 Director 27 Feb 2024, 17:03
DRMA Dermata Therapeutics, Inc. 04 Jan 2024 1 $0 4 Director 05 Jan 2024, 21:00
/report/000120919123040278-hale-david-f-2023-06-28 Oncternal Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 30 Jun 2023, 16:00
DRMA Dermata Therapeutics, Inc. 06 Oct 2022 1 $0 4 Director 07 Oct 2022, 17:06
DRMA Dermata Therapeutics, Inc. 07 Jul 2022 1 $0 4 Director 08 Jul 2022, 16:10
/report/000120919122038041-hale-david-f-2022-06-16 Oncternal Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 18:01
DRMA Dermata Therapeutics, Inc. 07 Apr 2022 1 $0 4 Director 08 Apr 2022, 19:12
DRMA Dermata Therapeutics, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 18:08
/report/000120919122008972-hale-david-f-2021-12-31 Oncternal Therapeutics, Inc. 31 Dec 2021 1 $0 5 Director 11 Feb 2022, 17:00
/report/000120919121069092-hale-david-f-2021-12-09 BIOCEPT INC 09 Dec 2021 3 -$1,807 4 Director 10 Dec 2021, 16:04
DRMA Dermata Therapeutics, Inc. 17 Aug 2021 14 $0 4 Director, 10%+ Owner 17 Aug 2021, 12:49
DRMA Dermata Therapeutics, Inc. 12 Aug 2021 0 $0 3 Director 12 Aug 2021, 19:35
/report/000120919121047388-hale-david-f-2021-07-16 BIOCEPT INC 16 Jul 2021 1 $0 4 Director 20 Jul 2021, 16:45
/report/000120919121045049-hale-david-f-2021-06-30 Oncternal Therapeutics, Inc. 30 Jun 2021 1 -$17,428 4 Director 02 Jul 2021, 17:01
/report/000120919121036313-hale-david-f-2021-05-25 Oncternal Therapeutics, Inc. 25 May 2021 1 $0 4 Director 27 May 2021, 18:06